Kui Huang

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States)
    Kui Huang
    Global Epidemiology, Pfizer Inc, Mail stop 150 3 80, 235 East 42nd Street, New York City, NY 10017 575, USA
    Cancer Causes Control 17:385-94. 2006
  2. ncbi Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study
    Kui Huang
    Pfizer Inc, New York, NY, USA
    Fam Cancer 10:303-8. 2011

Detail Information

Publications2

  1. ncbi GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case-control study in North Carolina (United States)
    Kui Huang
    Global Epidemiology, Pfizer Inc, Mail stop 150 3 80, 235 East 42nd Street, New York City, NY 10017 575, USA
    Cancer Causes Control 17:385-94. 2006
    ..GSTT1 and GSTM1 polymorphisms may be weakly related to colon cancer risk and there may be racial differences in gene-smoking interactions...
  2. ncbi Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study
    Kui Huang
    Pfizer Inc, New York, NY, USA
    Fam Cancer 10:303-8. 2011
    ..Long term celecoxib treatment appeared to be well tolerated in FAP patients with or without FAP-related surgeries...